Page URL:

Silencing 'junk' gene THOR could slow tumour growth

18 December 2017
Appeared in BioNews 931

Scientists in the USA have found a novel noncoding gene that alters proliferation in cancer cells to help tumour development.

The team, at the University of Michigan in Ann Arbor, identified THOR (Testis-associated Highly-conserved Oncogenic long noncoding RNA) while investigating an unexplored area of the genome harbouring a class of genes called long non-coding RNAs (ribonucleic acid) (lncRNAs). These genes do not contain information to make proteins, therefore they have long been regarded as 'junk' DNA. More recently, non-coding regions of the genome have proved to have diverse functions in health and disease.

The study, published in Cell, demonstrates that the newly discovered non-coding gene is highly conserved in different species, including humans, mice and zebrafish. 'Genes that are evolutionarily conserved are likely important for biological processes. The fact that we found THOR to be a highly conserved IncRNA was exciting,' said Dr Arul Chinnaiyan, who led the team.

When the researchers silenced THOR the tumour growth slowed down, instead THOR overexpression made tumours grow faster. Interestingly, THOR expression did not affect normal cells, suggesting a specific function of the gene in cancerous tissues.

THOR is highly expressed in tumours like melanoma and lung cancer and interacts with insulin-like growth factor-binding proteins, known to help stabilise RNA in the cells. 'If we perturb THOR function, we disturb the ability to stabilise RNA. This inhibits cell proliferation,' said Dr Chinnaiyan.

The research was conducted using in vitro systems and in animal models, so more studies are needed before the findings can be applied to patients.  Dr Chinnaiyan suggested that THOR could be a good drug target - in the future, a therapeutic compound could be developed to 'knock-out' the gene, rendering it silent. The team hopes to develop this using a complementary sequence known as antisense oligonucleotide that can bind with THOR.

Ancient gene called THOR discovered in human genome could be secret weapon against cancer
Newsweek |  14 December 2017
How defeating THOR could bring a hammer down on cancer
EurekAlert |  14 December 2017
Newly identified THOR gene could play a role in suppressing tumors
Fierce Biotech |  14 December 2017
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA
Cell |  14 December 2017
Silencing 'junk' gene could halt tumor growth
Medical News Today |  14 December 2017
9 August 2021 - by Georgina Al-Badri 
The mechanism underlying DNA damage that leads to melanoma has been found to be a specific mutation caused by UVB radiation in sunlight...
9 December 2019 - by Dr Nicoletta Charolidi 
Scientists have found that genetic variation in regions of DNA that do not code for proteins, previously characterised as 'junk DNA', may affect a person's risk to develop a form of inherited cancer...
20 August 2018 - by Dr Loredana Guglielmi 
For their large body size, elephants should get cancer a lot more often than they do – now a new study has found out why...
26 March 2018 - by Anna Mallach 
Changes in DNA outside that of genes can cause neurodevelopmental disorders, UK researchers have found...
11 December 2017 - by Shaoni Bhattacharya 
UK scientists say they are closer to developing an 'early warning system' for the return of cancer in patients using a simple blood test...
4 December 2017 - by Theofanis Michailidis 
The US Food and Drug Administration has approved a test which can detect cancer-causing mutations in 324 genes...
20 November 2017 - by Marcia Costa 
A team of scientists in Germany has developed a 'sensor' that detects mutations in the key tumour suppressor gene p53 and then kills potentially cancerous cells...
13 November 2017 - by Dr Loredana Guglielmi 
Researchers have introduced new criteria to screen for BRCA gene mutations that could prevent more than 10,000 cases of cancer and save more than 2000 lives in the next decade...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.